找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Cancer Gene Therapy; David T. Curiel,Joanne T. Douglas Book 2005 Humana Press 2005 cancer treatment.clinical trial.gene therapy.gene trans

[复制链接]
发表于 2025-3-25 04:57:37 | 显示全部楼层
发表于 2025-3-25 09:17:33 | 显示全部楼层
发表于 2025-3-25 14:48:00 | 显示全部楼层
A. Bonso,A. Rossillo,R. Valente,A. Ravielet is the history of the last few years that is largely dictating the research directions that will likely be both profitable and permitted in the future. This brief introductory chapter outlines the early days of cancer gene therapy—the successes and the setbacks—and suggests how the remaining chall
发表于 2025-3-25 18:58:16 | 显示全部楼层
发表于 2025-3-25 23:23:25 | 显示全部楼层
A. Bonso,A. Rossillo,R. Valente,A. RavieleTheodor Boveri . suggested “the presence of definite chromosomes which inhibit division.” Writing in 1914 (translation published in 1929), Boveri ventured that “cells of tumors with unlimited growth would arise if those ‘inhibiting chromosomes’ were eliminated.” Over half a century later, molecular
发表于 2025-3-26 02:26:06 | 显示全部楼层
https://doi.org/10.1007/978-88-470-2087-0nic genes (Fig. 1). In the past, the term . included several distinct but related approaches, including classical antisense or anticode, ribozyme or catalytic ribonucleic acid (RNA), triplex or antigene, and aptamer technologies (Table 1). A unified terminology has not yet been developed to describe
发表于 2025-3-26 06:44:45 | 显示全部楼层
发表于 2025-3-26 11:36:06 | 显示全部楼层
发表于 2025-3-26 14:44:38 | 显示全部楼层
发表于 2025-3-26 20:36:30 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-5 00:37
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表